Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
British Journal of Cancer
|
July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
J Rees, C N Hurt, S Gollins, et al.
British Journal of Cancer
|
August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study
J W Valle, H Wasan, P Johnson, et al.
Heliyon
|
September 28, 2018
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)
R Glynne-Jones, M R Hall, A Lopes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2005
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer
G Chong, A Bhatnagar, D Cunningham, et al.
BMC Cancer
|
October 24, 2015
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
R Glynne-Jones, N Hava, V Goh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
H Blons, J F Emile, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients
J Taieb, R Balogoun, K Le Malicot, et al.
British Journal of Cancer
|
May 1, 2020
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma
P G Corrie, W Qian, B Basu, et al.
Allergy
|
November 19, 2017
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project
A Bonertz, G Roberts, J E Slater, et al.
Allergy
|
August 4, 2017
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products
A Bonertz, G C Roberts, M Hoefnagel, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
British Journal of Cancer
|
July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
J Rees, C N Hurt, S Gollins, et al.
British Journal of Cancer
|
August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study
J W Valle, H Wasan, P Johnson, et al.
Heliyon
|
September 28, 2018
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)
R Glynne-Jones, M R Hall, A Lopes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2005
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer
G Chong, A Bhatnagar, D Cunningham, et al.
BMC Cancer
|
October 24, 2015
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
R Glynne-Jones, N Hava, V Goh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2014
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
H Blons, J F Emile, K Le Malicot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 30, 2016
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients
J Taieb, R Balogoun, K Le Malicot, et al.
British Journal of Cancer
|
May 1, 2020
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma
P G Corrie, W Qian, B Basu, et al.
Allergy
|
November 19, 2017
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project
A Bonertz, G Roberts, J E Slater, et al.
Allergy
|
August 4, 2017
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products
A Bonertz, G C Roberts, M Hoefnagel, et al.
Page
of 6